Two Patients with Advance-Stage Renal Cell Carcinoma Developed Sunitinib-Related Skin Toxicity

Mehmet Cetinkaya, Ozgur Tanriverdi, Hasan Deliktas, Asude Kara, Yelda Dere and Hayrettin Sahin

Department of Urology, School of Medicine, Mugla Sitki Kocman University, Mugla, Turkey
Department of Medical Oncology, School of Medicine, Mugla Sitki Kocman University, Mugla, Turkey
Department of Dermatology, Mugla Sitki Kocman University Training and Research Hospital, Mugla, Turkey
Department of Pathology, School of Medicine, Mugla Sitki Kocman University, Mugla, Turkey

^*Correspondance to: Mehmet Cetinkaya 

 PDF  Full Text Case Report | Open Access

Abstract:

With the current treatment modalities like molecular targeted therapy, general survival rates have increased in patients with advanced-stage renal cell carcinoma. Sunitinib maleate is one of these drugs and its most frequently side effects are fatigue, diarrhea, hypertension, stomatitis, and hair hypo-pigmentation. Additionally, various dermatological side-effects may also be seen such as handfoot syndrome, a yellowish color change to the face, splinter hemorrhage, erythematous reactions on the trunk, facial edema, facial erythematous changes, alopecia, acneiform rash on the face and dysesthesia in the scalp. Although Sunitinib maleate-related scrotal skin toxicity is extremely rarely seen, it should not be forgotten that this side-effect can be easily managed. Herein, we report two cases with Sunitinib maleate-related scrotal skin toxicity, which were diagnosed with advancedstage renal cell carcinoma in this case report.

Keywords:

Sunitinib; Kidney cancer; Scrotal cutaneous toxicity; Molecular targeted therapy

Cite the Article:

Cetinkaya M, Tanriverdi O, Deliktas H, Kara A, Dere Y, Sahin H. Two Patients with Advance-Stage Renal Cell Carcinoma Developed Sunitinib- Related Skin Toxicity. Clin Oncol. 2017; 2: 1269.